STAAR Surgical | STAA - Gross Profit On Sales


STAAR Surgical reported $77.88M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Bausch Health Companies USD 1.93B 165M Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Cooper Companies USD 650.8M 62.6M Sep/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Hologic USD 586.4M 2.9M Dec/2025
J&J USD 16.6B 118M Dec/2025
Merit Medical Systems USD 195.35M 8.94M Dec/2025
Novartis USD 10.82B 695M Sep/2025
OraSure Technologies USD 17.07M 7.62M Sep/2024
Orthofix International USD 545.88M 410.83M Dec/2024
Rockwell Medical USD 4.55M 1.49M Jun/2024
STAAR Surgical USD 77.88M 45.08M Sep/2025
Utah Medical Products USD 5.8M 450K Sep/2024